These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21465945)

  • 1. Usefulness of S100B protein in neurological disorders.
    Yardan T; Erenler AK; Baydin A; Aydin K; Cokluk C
    J Pak Med Assoc; 2011 Mar; 61(3):276-81. PubMed ID: 21465945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications.
    Kleindienst A; Hesse F; Bullock MR; Buchfelder M
    Prog Brain Res; 2007; 161():317-25. PubMed ID: 17618987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100B in neuropathologic states: the CRP of the brain?
    Sen J; Belli A
    J Neurosci Res; 2007 May; 85(7):1373-80. PubMed ID: 17348038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury.
    Kleindienst A; Ross Bullock M
    J Neurotrauma; 2006 Aug; 23(8):1185-200. PubMed ID: 16928177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100B in brain damage and neurodegeneration.
    Rothermundt M; Peters M; Prehn JH; Arolt V
    Microsc Res Tech; 2003 Apr; 60(6):614-32. PubMed ID: 12645009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular fluid S100B in the injured brain: a future surrogate marker of acute brain injury?
    Sen J; Belli A; Petzold A; Russo S; Keir G; Thompson EJ; Smith M; Kitchen N
    Acta Neurochir (Wien); 2005 Aug; 147(8):897-900. PubMed ID: 15824882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and methodological features of the measurement of S100B, a putative marker of brain injury.
    Gonçalves CA; Leite MC; Nardin P
    Clin Biochem; 2008 Jul; 41(10-11):755-63. PubMed ID: 18454941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia.
    Wainwright MS; Craft JM; Griffin WS; Marks A; Pineda J; Padgett KR; Van Eldik LJ
    Ann Neurol; 2004 Jul; 56(1):61-7. PubMed ID: 15236402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain.
    Van Eldik LJ; Wainwright MS
    Restor Neurol Neurosci; 2003; 21(3-4):97-108. PubMed ID: 14530573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100 B: A new concept in neurocritical care.
    Rezaei O; Pakdaman H; Gharehgozli K; Simani L; Vahedian-Azimi A; Asaadi S; Sahraei Z; Hajiesmaeili M
    Iran J Neurol; 2017 Apr; 16(2):83-89. PubMed ID: 28761630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults.
    Rodríguez-Rodríguez A; Egea-Guerrero JJ; León-Justel A; Gordillo-Escobar E; Revuelto-Rey J; Vilches-Arenas A; Carrillo-Vico A; Domínguez-Roldán JM; Murillo-Cabezas F; Guerrero JM
    Clin Chim Acta; 2012 Dec; 414():228-33. PubMed ID: 23031665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.
    Michetti F; Corvino V; Geloso MC; Lattanzi W; Bernardini C; Serpero L; Gazzolo D
    J Neurochem; 2012 Mar; 120(5):644-59. PubMed ID: 22145907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [S100B: astrocyte specific protein].
    Tateishi N; Shimoda T; Yada N; Shinagawa R; Kagamiishi Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Feb; 26(1):11-6. PubMed ID: 16637591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100B is not a reliable prognostic index in paediatric TBI.
    Piazza O; Storti MP; Cotena S; Stoppa F; Perrotta D; Esposito G; Pirozzi N; Tufano R
    Pediatr Neurosurg; 2007; 43(4):258-64. PubMed ID: 17627141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of S100B in predicting severity of central nervous system injury.
    Bloomfield SM; McKinney J; Smith L; Brisman J
    Neurocrit Care; 2007; 6(2):121-38. PubMed ID: 17522796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100B protein in neurodegenerative disorders.
    Steiner J; Bogerts B; Schroeter ML; Bernstein HG
    Clin Chem Lab Med; 2011 Mar; 49(3):409-24. PubMed ID: 21303299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of S100B protein in neoplasms and other diseases].
    Bánfalvi T; Gergye M; Beczássy E; Gilde K; Ottó S
    Magy Onkol; 2004; 48(1):71-4. PubMed ID: 15105899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice.
    Vives V; Alonso G; Solal AC; Joubert D; Legraverend C
    J Comp Neurol; 2003 Mar; 457(4):404-19. PubMed ID: 12561079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E increases S100B-mediated microglial activation in an S100B-overexpressing mouse model of pathological aging.
    Bialowas-McGoey LA; Lesicka A; Whitaker-Azmitia PM
    Glia; 2008 Dec; 56(16):1780-90. PubMed ID: 18649404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP.
    Wiesmann M; Steinmeier E; Magerkurth O; Linn J; Gottmann D; Missler U
    Acta Neurol Scand; 2010 Mar; 121(3):178-85. PubMed ID: 19804476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.